| Patent | Date |
|---|
Ret Kinase Inhibitors
App 20220144816 - Kolakowski; Gabrielle R. ; et al. | 2022-05-12 |
Substituted Pyrazolo[1,5-a]pyrazine Compounds As Ret Kinase Inhibitors
App 20220119396 - ANDREWS; Steven W. ; et al. | 2022-04-21 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
Grant 11,267,818 - Haas , et al. March 8, 2 | 2022-03-08 |
Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrim- idin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereof
Grant 11,214,571 - Reynolds , et al. January 4, 2 | 2022-01-04 |
Compounds Useful For Inhibiting Ret Kinase
App 20210363140 - ANDERSON; Erin D. ; et al. | 2021-11-25 |
Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors
Grant 11,168,090 - Andrews , et al. November 9, 2 | 2021-11-09 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20210186959 - Andrews; Steven W. ; et al. | 2021-06-24 |
Point Mutations In Trk Inhibitor-resistant Cancer And Methods Relating To The Same
App 20210164055 - Nanda; Nisha ; et al. | 2021-06-03 |
Macrocyclic compounds as ROS1 kinase inhibitors
Grant 10,966,985 - Andrews , et al. April 6, 2 | 2021-04-06 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
Grant 10,953,005 - Andrews , et al. March 23, 2 | 2021-03-23 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same
Grant 10,907,215 - Nanda , et al. February 2, 2 | 2021-02-02 |
Method Of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds
App 20210002287 - Haas; Julia ; et al. | 2021-01-07 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,881,652 - Andrews , et al. January 5, 2 | 2021-01-05 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20200383966 - ANDREWS; Steven W. ; et al. | 2020-12-10 |
1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-met- hyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor
Grant 10,835,533 - Allen , et al. November 17, 2 | 2020-11-17 |
Macrocyclic Compounds As Trk Kinase Inhibitors
App 20200291026 - Andrews; Steven W. ; et al. | 2020-09-17 |
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
Grant 10,774,085 - Haas , et al. Sept | 2020-09-15 |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
Grant 10,766,881 - Andrews , et al. Sep | 2020-09-08 |
Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors
Grant 10,758,542 - Allen , et al. Sep | 2020-09-01 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same
Grant 10,724,102 - Nanda , et al. | 2020-07-28 |
Macrocylic compounds as ROS1 kinase inhibitors
Grant 10,688,100 - Andrews , et al. | 2020-06-23 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same
Grant 10,655,186 - Nanda , et al. | 2020-05-19 |
Macrocyclic compounds as TRK kinase inhibitors
Grant 10,647,730 - Andrews , et al. | 2020-05-12 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
Grant 10,590,139 - Andrews , et al. | 2020-03-17 |
Substituted Pyrazolo[1,5-a]pyrazine Compounds As Ret Kinase Inhibitors
App 20200055860 - ANDREWS; Steven W ; et al. | 2020-02-20 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,555,944 - Andrews , et al. Feb | 2020-02-11 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20200030311 - ANDREWS; Steven W. ; et al. | 2020-01-30 |
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
App 20190365763 - Allen; Shelley ; et al. | 2019-12-05 |
Pyrrolidinyl Urea, Pyrrolidinyl Thiourea And Pyrrolidinyl Guanidine Compounds As Trka Kinase Inhibitors
App 20190359597 - Allen; Shelley ; et al. | 2019-11-28 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,441,581 - Andrews , et al. Oc | 2019-10-15 |
2-aryl- And 2-heteroaryl-substituted 2-pyridazin-3(2h)-one Compounds As Inhibitors Of Fgfr Tyrosine Kinases
App 20190300511 - Andrews; Steven W. ; et al. | 2019-10-03 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same
Grant 10,378,068 - Nanda , et al. A | 2019-08-13 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same
Grant 10,370,727 - Nanda , et al. | 2019-08-06 |
Process For The Preparation Of (s)-n-(5-((r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrim- Idin-3-yl)-3-hydroxypy
App 20190218222 - Reynolds; Mark ; et al. | 2019-07-18 |
Method Of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds
App 20190211017 - Haas; Julia ; et al. | 2019-07-11 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20190183886 - Andrews; Steven W. ; et al. | 2019-06-20 |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
Grant 10,323,022 - Allen , et al. | 2019-06-18 |
Method of Treatment Using Substituted Imidazo[1,2b]Pyridazine Compounds
App 20190169193 - Andrews; Steven W. ; et al. | 2019-06-06 |
Macrocyclic Compounds As Ros1 Kinase Inhibitors
App 20190151322 - Andrews; Steven W. ; et al. | 2019-05-23 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20190127373 - Andrews; Steven W. ; et al. | 2019-05-02 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20190127374 - Andrews; Steven W. ; et al. | 2019-05-02 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20190127375 - Andrews; Steven W. ; et al. | 2019-05-02 |
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
Grant 10,251,889 - Allen , et al. | 2019-04-09 |
Macrocyclic Compounds As Ros1 Kinase Inhibitors
App 20190076437 - Andrews; Steven W. ; et al. | 2019-03-14 |
Macrocyclic Compounds As Ros1 Kinase Inhibitors
App 20190076436 - Andrews; Steven W. ; et al. | 2019-03-14 |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
Grant 10,208,024 - Andrews , et al. Feb | 2019-02-19 |
Macrocyclic Compounds As Trk Kinase Inhibitors
App 20190031684 - Andrews; Steven W. ; et al. | 2019-01-31 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,172,845 - Andrews , et al. J | 2019-01-08 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,172,851 - Andrews , et al. J | 2019-01-08 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,174,028 - Andrews , et al. J | 2019-01-08 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
Grant 10,174,027 - Andrews , et al. J | 2019-01-08 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,144,734 - Andrews , et al. De | 2018-12-04 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
Grant 10,138,243 - Andrews , et al. Nov | 2018-11-27 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
Grant 10,137,124 - Andrews , et al. November 27, 2 | 2018-11-27 |
Pyrrolidinyl Urea, Pyrrolidinyl Thiourea And Pyrrolidinyl Guanidine Compounds As Trka Kinase Inhibitors
App 20180334450 - Allen; Shelley ; et al. | 2018-11-22 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,112,942 - Andrews , et al. October 30, 2 | 2018-10-30 |
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
App 20180263984 - Allen; Shelley ; et al. | 2018-09-20 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
Grant 10,047,097 - Haas , et al. August 14, 2 | 2018-08-14 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,023,570 - Andrews , et al. July 17, 2 | 2018-07-17 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180186790 - Andrews; Steven W. ; et al. | 2018-07-05 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180186791 - Andrews; Steven W. ; et al. | 2018-07-05 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
Grant 10,011,604 - Andrews , et al. July 3, 2 | 2018-07-03 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180179203 - Andrews; Steven W. ; et al. | 2018-06-28 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
Grant 10,005,783 - Haas , et al. June 26, 2 | 2018-06-26 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180148445 - Andrews; Steven W. ; et al. | 2018-05-31 |
Point Mutations In Trk Inhibitor-resistant Cancer And Methods Relating To The Same
App 20180142306 - Nanda; Nisha ; et al. | 2018-05-24 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180133213 - Andrews; Steven W. ; et al. | 2018-05-17 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180133200 - Andrews; Steven W. ; et al. | 2018-05-17 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180133207 - Andrews; Steven W. ; et al. | 2018-05-17 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180134702 - Andrews; Steven W. ; et al. | 2018-05-17 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180134703 - Andrews; Steven W. ; et al. | 2018-05-17 |
Method Of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds
App 20180127427 - Haas; Julia ; et al. | 2018-05-10 |
Point Mutations In Trk Inhibitor-resistant Cancer And Methods Relating To The Same
App 20180119228 - Nanda; Nisha ; et al. | 2018-05-03 |
Macrocyclic compounds as TRK kinase inhibitors
Grant 9,902,741 - Andrews , et al. February 27, 2 | 2018-02-27 |
Point Mutations In Trk Inhibitor-resistant Cancer And Methods Relating To The Same
App 20180030549 - Nanda; Nisha ; et al. | 2018-02-01 |
Point Mutations In Trk Inhibitor-resistant Cancer And Methods Relating To The Same
App 20180030548 - Nanda; Nisha ; et al. | 2018-02-01 |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
Grant 9,878,997 - Allen , et al. January 30, 2 | 2018-01-30 |
Macrocyclic compounds as TRK kinase inhibitors
Grant 9,840,519 - Andrews , et al. December 12, 2 | 2017-12-12 |
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
Grant 9,796,724 - Allen , et al. October 24, 2 | 2017-10-24 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
Grant 9,795,611 - Andrews , et al. October 24, 2 | 2017-10-24 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
Grant 9,796,723 - Andrews , et al. October 24, 2 | 2017-10-24 |
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
Grant 9,782,415 - Allen , et al. October 10, 2 | 2017-10-10 |
Macrocyclic Compounds As Trk Kinase Inhibitors
App 20170283435 - Andrews; Steven W. ; et al. | 2017-10-05 |
Point Mutations In Trk Inhibitor-resistant Cancer And Methods Relating To The Same
App 20170260589 - Nanda; Nisha ; et al. | 2017-09-14 |
2-aryl- And 2-heteroaryl-substituted 2-pyridazin-3(2h)-one Compounds As Inhibitors Of Fgfr Tyrosine Kinases
App 20170260168 - Andrews; Steven W. ; et al. | 2017-09-14 |
Macrocyclic compounds as Trk kinase inhibitors
Grant 9,750,744 - Andrews , et al. September 5, 2 | 2017-09-05 |
Pyrrolidinyl Urea, Pyrrolidinyl Thiourea And Pyrrolidinyl Guanidine Compounds As Trka Kinase Inhibitors
App 20170217936 - Allen; Shelley ; et al. | 2017-08-03 |
Macrocyclic compounds as Trk kinase inhibitors
Grant 9,718,822 - Andrews , et al. August 1, 2 | 2017-08-01 |
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
Grant 9,676,783 - Haas , et al. June 13, 2 | 2017-06-13 |
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
App 20170119770 - Allen; Shelley ; et al. | 2017-05-04 |
Macrocyclic Compounds As Trk Kinase Inhibitors
App 20170112842 - Andrews; Steven W. ; et al. | 2017-04-27 |
Method of Treatment Using Substituted Imidazo[1,2b]Pyridazine Compounds
App 20170112849 - Andrews; Steven W. ; et al. | 2017-04-27 |
Method Of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds
App 20170114067 - Haas; Julia ; et al. | 2017-04-27 |
Method of Treatment Using Substituted Imidazo[1,2b]Pyridazine Compounds
App 20170114068 - Andrews; Steven W. ; et al. | 2017-04-27 |
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
App 20170114069 - Allen; Shelley ; et al. | 2017-04-27 |
Macrocyclic Compounds As Trk Kinase Inhibitors
App 20170114059 - Andrews; Steven W. ; et al. | 2017-04-27 |
Macrocyclic Compounds As Trk Kinase Inhibitors
App 20170107232 - Andrews; Steven W. ; et al. | 2017-04-20 |
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20170096425 - Andrews; Steven W. ; et al. | 2017-04-06 |
1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-meth- Yl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea As A Trka Kinase Inhibitor
App 20170087156 - Allen; Shelley ; et al. | 2017-03-30 |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
Grant 9,562,055 - Allen , et al. February 7, 2 | 2017-02-07 |
Macrocyclic compounds as trk kinase inhibitors
Grant 9,493,476 - Andrews , et al. November 15, 2 | 2016-11-15 |
Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
Grant 9,447,104 - Haas , et al. September 20, 2 | 2016-09-20 |
Method of Treatment Using Substituted Imidazo[1,2b]Pyridazine Compounds
App 20160251357 - Andrews; Steven W. ; et al. | 2016-09-01 |
Method Of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds
App 20160228441 - Haas; Julia ; et al. | 2016-08-11 |
Method of treatment using substituted imidazo[1,2B]pyridazine compounds
Grant 9,227,975 - Andrews , et al. January 5, 2 | 2016-01-05 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
Grant 9,127,013 - Haas , et al. September 8, 2 | 2015-09-08 |
Pyrrolidinyl Urea, Pyrrolidinyl Thiourea And Pyrrolidinyl Guanidine Compounds As Trka Kinase Inhibitors
App 20150166564 - Allen; Shelley ; et al. | 2015-06-18 |
METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-a] PYRIMIDINE COMPOUNDS
App 20150133429 - Haas; Julia ; et al. | 2015-05-14 |
METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS
App 20150005499 - Haas; Julia ; et al. | 2015-01-01 |
Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
Grant 8,865,698 - Haas , et al. October 21, 2 | 2014-10-21 |
Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
Grant 8,865,726 - Andrews , et al. October 21, 2 | 2014-10-21 |
METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS
App 20140194403 - Haas; Julia ; et al. | 2014-07-10 |
Method Of Treatment Using Substituted Imidazo[1,2b]pyridazine Compounds
App 20130217662 - Andrews; Steven W. ; et al. | 2013-08-22 |
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
Grant 8,513,263 - Haas , et al. August 20, 2 | 2013-08-20 |
Macrocyclic inhibitors of hepatitis C virus replication
Grant 8,299,021 - Blatt , et al. October 30, 2 | 2012-10-30 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
App 20120208995 - Blatt; Lawrence M. ; et al. | 2012-08-16 |
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
App 20120178715 - Andrews; Steven W. ; et al. | 2012-07-12 |
Non-acidic Cyclopentane Heptanoic Acid, 2-cycloalkyl Or Arylalkyl Derivatives As Therapeutic Agents
App 20110294893 - Woodward; David F. ; et al. | 2011-12-01 |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Grant 8,017,655 - Woodward , et al. September 13, 2 | 2011-09-13 |
Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors
App 20110195948 - Haas; Julia ; et al. | 2011-08-11 |
SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS
App 20110166122 - Andrews; Steven W. ; et al. | 2011-07-07 |
Peptide inhibitors of hepatitis C virus replication
Grant 7,932,277 - Seiwert , et al. April 26, 2 | 2011-04-26 |
Macrocyclic inhibitors of hepatitis C virus replication
Grant 7,829,665 - Blatt , et al. November 9, 2 | 2010-11-09 |
Inhibitors of hepatitis C virus replication
Grant 7,781,474 - Seiwert , et al. August 24, 2 | 2010-08-24 |
Novel Inhibitors Of Hepatitis C Virus Replication
App 20100209391 - SEIWERT; SCOTT ; et al. | 2010-08-19 |
Cyclopropane compounds and pharmaceutical use thereof
App 20100105894 - Inaba; Takashi ; et al. | 2010-04-29 |
Novel Peptide Inhibitors Of Hepatitis C Virus Replication
App 20090297476 - SEIWERT; SCOTT ; et al. | 2009-12-03 |
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090286843 - BLATT; LAWRENCE M. ; et al. | 2009-11-19 |
Non-acidic Cyclopentane Heptanoic Acid, 2-cycloalkyl Or Arylalkyl Derivatives As Therapeutic Agents
App 20090227672 - Woodward; David F. ; et al. | 2009-09-10 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
App 20090169510 - Blatt; Lawrence M ; et al. | 2009-07-02 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
App 20090155209 - BLATT; LAWRENCE M. ; et al. | 2009-06-18 |
Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
App 20090148407 - Blatt; Lawrence M. ; et al. | 2009-06-11 |
Kinase inhibitors for the treatment of disease
Grant 7,531,665 - Andrews , et al. May 12, 2 | 2009-05-12 |
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090111969 - Blatt; Lawrence M. ; et al. | 2009-04-30 |
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090111982 - Blatt; Lawrence M. ; et al. | 2009-04-30 |
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090105471 - Blatt; Lawrence M. ; et al. | 2009-04-23 |
Inhibitors Of Viral Replication
App 20090099186 - Beigelman; Leonid ; et al. | 2009-04-16 |
Novel Inhibitors Of Hepatitis C Virus Replication
App 20090047246 - Beigelman; Leonid ; et al. | 2009-02-19 |
Macrocyclic compounds as inhibitors of viral replication
Grant 7,491,794 - Blatt , et al. February 17, 2 | 2009-02-17 |
Cyclopropane compounds and pharmaceutical use thereof
App 20080306258 - Inaba; Takashi ; et al. | 2008-12-11 |
Cyclopropane Compounds And Pharmaceutical Use Thereof
App 20080261994 - INABA; Takashi ; et al. | 2008-10-23 |
N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
App 20080242656 - Fryer; Andrew M. ; et al. | 2008-10-02 |
3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 7,414,054 - Andrews , et al. August 19, 2 | 2008-08-19 |
3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 7,393,870 - Andrews , et al. July 1, 2 | 2008-07-01 |
Cyclopropane compounds and pharmaceutical use thereof
Grant 7,351,825 - Inaba , et al. April 1, 2 | 2008-04-01 |
Novel Inhibitors Of Hepatitis C Virus Replication
App 20080019942 - Seiwert; Scott ; et al. | 2008-01-24 |
Novel macrocyclic inhibitors of hepatitis C virus replication
App 20070054842 - Blatt; Lawrence M. ; et al. | 2007-03-08 |
Cyclopropane compounds and pharmaceutical use thereof
App 20060199826 - Inaba; Takashi ; et al. | 2006-09-07 |
3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20060194863 - Andrews; Steven W. ; et al. | 2006-08-31 |
3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 7,098,236 - Andrews , et al. August 29, 2 | 2006-08-29 |
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 7,060,844 - Andrews , et al. June 13, 2 | 2006-06-13 |
3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20060074116 - Andrews; Steven W. ; et al. | 2006-04-06 |
3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20060063940 - Andrews; Steven W. ; et al. | 2006-03-23 |
3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 7,015,220 - Andrews , et al. March 21, 2 | 2006-03-21 |
3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 7,005,444 - Andrews , et al. February 28, 2 | 2006-02-28 |
3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20060025413 - Andrews; Steven W. ; et al. | 2006-02-02 |
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20060004084 - Andrews; Steven W. ; et al. | 2006-01-05 |
Macrocyclic compounds as inhibitors of viral replication
App 20050267018 - Blatt, Lawrence M. ; et al. | 2005-12-01 |
3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20050228036 - Andrews, Steven W. ; et al. | 2005-10-13 |
N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
App 20050222146 - Fryer, Andrew M. ; et al. | 2005-10-06 |
3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20040198720 - Andrews, Steven W. ; et al. | 2004-10-07 |
Kinase inhibitors for the treatment of disease
App 20040198802 - Andrews, Steven W. ; et al. | 2004-10-07 |
3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 6,765,012 - Andrews , et al. July 20, 2 | 2004-07-20 |
Kinase inhibitors for the treatment of disease
Grant 6,747,025 - Andrews , et al. June 8, 2 | 2004-06-08 |
Kinase Inhibitors For The Treatment Of Disease
App 20040102509 - Andrews, Steven W. ; et al. | 2004-05-27 |
Kinase inhibitors for the treatment of disease
Grant 6,699,863 - Andrews , et al. March 2, 2 | 2004-03-02 |
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20040019098 - Andrews, Steven W. ; et al. | 2004-01-29 |
3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
App 20030225152 - Andrews, Steven W. ; et al. | 2003-12-04 |
3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20030199478 - Andrews, Steven W. ; et al. | 2003-10-23 |
3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
App 20030130328 - Andrews, Steven W. ; et al. | 2003-07-10 |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
App 20030114528 - Woodward, David F. ; et al. | 2003-06-19 |
3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
Grant 6,559,173 - Andrews , et al. May 6, 2 | 2003-05-06 |
Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Grant 6,403,649 - Woodward , et al. June 11, 2 | 2002-06-11 |
Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents
Grant 6,258,844 - Garst , et al. July 10, 2 | 2001-07-10 |
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Grant 5,688,819 - Woodward , et al. November 18, 1 | 1997-11-18 |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Grant 5,607,978 - Woodward , et al. March 4, 1 | 1997-03-04 |
Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
Grant 5,387,608 - Andrews February 7, 1 | 1995-02-07 |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Grant 5,352,708 - Woodward , et al. October 4, 1 | 1994-10-04 |
| 